Disease burden and patient characteristics associated with systemic therapy utilization among adults with atopic dermatitis: data from CorEvitas Atopic Dermatitis Registry

• Príomhchruthaitheoirí: Jonathan I. Silverberg (Údar), Linda Stein Gold (Údar), Seemal Desai (Údar), Alexandra Golant (Údar), Douglas DiRuggiero (Údar), D. Christian Fenske (Údar), Alvin Li (Údar), Zach Dawson (Údar), Yolanda Muñoz Maldonado (Údar), Kaylee Ho (Údar), Kayla Callahan (Údar), Eric L. Simpson (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Background The decision to initiate advanced systemics in patients with atopic dermatitis (AD) is complex.Objectives To explore disease burden and clinical characteristics of patients with moderate-to-severe AD and identify characteristics associated with initiating new systemics.Methods Data from p...